BAY Share Price

Open 105.20 Change Price %
High 105.40 1 Day -1.00 -0.95
Low 103.90 1 Week -2.00 -1.88
Close 104.30 1 Month 3.00 2.96
Volume 1123 1 Year 9.50 10.02
52 Week High 113.00
52 Week Low 83.80
BAY Important Levels
Resistance 2 105.69
Resistance 1 105.12
Pivot 104.53
Support 1 103.48
Support 2 102.91
BIT Italy Most Active Stocks
SPM 0.42 -6.67%
SPM 0.42 -6.67%
ISP 2.07 -2.36%
PMI 0.36 0.00%
PMI 0.36 0.00%
TIT 0.76 -1.30%
ENEL 4.02 1.26%
F 6.94 -2.12%
F 6.94 -2.12%
F 6.94 -2.12%
BIT Italy Top Gainers Stocks
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
EEMS 0.14 16.67%
TAS 4.07 12.74%
TAS 4.07 12.74%
TAS 4.07 12.74%
POPR 0.32 6.67%
VRW 1.13 6.60%
BIT Italy Top Losers Stocks
PRS 0.09 -10.00%
PRS 0.09 -10.00%
PRS 0.09 -10.00%
PRS 0.09 -10.00%
SPMR 5.41 -9.83%
MCH 0.67 -6.94%
MCH 0.67 -6.94%
MCH 0.67 -6.94%
SPM 0.42 -6.67%
SPM 0.42 -6.67%

Bayer AG (BIT: BAY)

BAY Technical Analysis 3
As on 24th Feb 2017 BAY Share Price closed @ 104.30 and we RECOMMEND Buy for LONG-TERM with Stoploss of 95.39 & Buy for SHORT-TERM with Stoploss of 101.65 we also expect STOCK to react on Following IMPORTANT LEVELS.
BAY Target for February
1st Target up-side 107.93
2nd Target up-side 111.18
3rd Target up-side 114.43
1st Target down-side 98.67
2nd Target down-side 95.42
3rd Target down-side 92.17
BAY Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website
BAY Address
Kaiser-Wilhelm-Allee 1
Leverkusen, 51368
Phone: 49 214 301
BAY Latest News
Prior job cuts lead to surplus of space, which Bayer now hopes to fill with ...   San Francisco Business Times   - 24th Feb 17
Bayer touts Xarelto strength on heels of COMPASS data   BioPharma Dive   - 23rd Feb 17
Bayer's Q4: Mixed Signals For Investors   Seeking Alpha   - 23rd Feb 17
Bayer (BAYRY) Misses on Q4 Earnings; Revenues in Line   Nasdaq   - 23rd Feb 17
Champs League loss to Atleti exposes Bayer Leverkusen's deficiencies   ESPN FC (blog)   - 23rd Feb 17
Essure problems cost Bayer $413 million last year alone   - 23rd Feb 17
Bayer plans to complete Monsanto takeover by end of year   Delta Farm Press   - 23rd Feb 17
We price drugs in line with innovation potential, says Bayer CEO   CNBC   - 22nd Feb 17
What to watch in Bayer earnings   MarketWatch   - 21st Feb 17
Bayer Partners with NC FFA to Fund $10000 Project: "Respond and Rebuild"   PR Newswire (press release)   - 20th Feb 17
Interactive Technical Analysis Chart Bayer AG ( BAY BIT Italy )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Bayer AG
BAY Business Profile
Bayer Aktiengesellschaft develops, produces, and markets health care and agricultural products, and high-tech polymer materials worldwide. The company operates through HealthCare, CropScience, and MaterialScience segments. The HealthCare segment offers prescription pharmaceuticals, such as contraceptives, hemophilia treatments, anticoagulants, and medicines to treat multiple sclerosis, cancer, hypertension, and infectious diseases; and consumer health products comprising over-the-counter medications, dermatology products, nutritional supplements, veterinary medicines, and animal grooming products. This segment also provides medical care products, including blood glucose monitoring devices, such as single-strip and multi-strip systems; USB meters that feature integrated diabetes management software and direct plug-in to computers; contrast agent injection systems for diagnostic and therapeutic medical procedures in computed tomography, magnetic resonance imaging, and molecular imaging; and mechanical systems for removing thrombi from blood vessels, as well as service products for its systems. The CropScience segment offers products for use in agriculture as insecticides, fungicides, and herbicides or seed treatments; seeds and plant traits; and various products for gardens, green industry, and nonagricultural pest control. The MaterialScience segment provides high-tech polymer materials in the areas of polyurethanes, polycarbonates, coating and adhesive raw materials, and functional films; and produces and markets inorganic basic chemicals. The company has a strategic alliance with OncoMed Pharmaceuticals, Inc. to develop drugs to target cancer stem cell therapeutics. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.